EHA president-elect Prof Gribbin speaks with ecancer at EHA 23 about the development of EHA Topics in Focus, and the educational emphasis being placed on CAR-T cell immunotherapy.

He discusses the reasoning behind developing Topics in Focus from the conference, and the current state of access to the latest immunotherapies on an individual and national level.

Prof Gribbin emphasises the educational opportunities of EHA membership, meetings, and collaborations in developing leading haematological care.

For more on EHA Topics in Focus, watch our interview with current EHA president Prof Pieter Sonneveld.